66658-0112 Kepivance - CanMED: NDC

Product NDC:

66658-0112

Brand Name:

Kepivance

Generic Name:

Palifermin

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: Palifermin

Strength: 6.25

Unit: mg/1.2mL

Packages:

Code: 66658-0112-01

Description:

Effective Date: Nov. 14, 2012

Discontinued: April 30, 2023

Code: 66658-0112-03

Description: 3 VIAL, SINGLE-USE in 1 CARTON (66658-112-03) / 1.2 mL in 1 VIAL, SINGLE-USE (66658-112-01)

Effective Date: Dec. 15, 2009

Discontinued: April 20, 2023

Code: 66658-0112-06

Description: 6 VIAL, SINGLE-USE in 1 CARTON (66658-112-06) / 1.2 mL in 1 VIAL, SINGLE-USE (66658-112-01)

Effective Date: Dec. 15, 2009

Discontinued: April 20, 2023

Code: 66658-0112-24

Description:

Effective Date: Dec. 15, 2009

Discontinued: April 1, 2016

SEER*Rx Category:

Ancillary Therapy

Major Class:

Epithelial Growth Factor

Minor Class:

Keratinocyte Growth Factor/rHuKGF

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox